Parkinson's disease is formally diagnosed when a person presents with bradykinesia, defined as slowness of movement, along with at least one additional motor symptom such as tremor, rigidity, or postural instability. But the neurodegeneration underlying Parkinson's may begin well before any of those motor features become apparent.
Researchers now recognize a prodromal phase, a period during which the disease process may be underway but the clinical criteria for diagnosis have not yet been met, that can precede a formal Parkinson's diagnosis by a decade or more. Understanding what happens during that window, and what signs may emerge, is increasingly central to how clinicians and researchers think about this condition.
Published on:
June 8, 2026
Category:
Parkinsons
Among the best-characterized prodromal features of Parkinson's disease are symptoms that have nothing to do with movement. Loss of sense of smell, known as hyposmia or anosmia, can be one of the earliest and more consistent findings. Olfactory impairment affects up to 90% of people with Parkinson's at the time of motor diagnosis, and is thought to reflect Lewy body pathology in the olfactory bulb.
Chronic constipation has been studied as another potential early marker. Research published in peer-reviewed neurology literature has documented constipation appearing as many as 20 years before the onset of motor symptoms of Parkinson's disease, one of the earliest recognizable prodromal features identified to date.
REM sleep behavior disorder (RBD), a condition in which individuals physically act out vivid dreams, sometimes with kicking or shouting, may be considered among the most predictive prodromal markers.
Beyond smell loss, sleep disturbances, and constipation, the prodromal phase of Parkinson's disease may include mood changes such as depression and anxiety. Blood pressure drops upon standing (orthostatic hypotension), urinary dysfunction, and, in some individuals, reduced facial expression or voice changes may also appear during this period.
Mild motor changes may also be present during the prodromal phase without meeting full diagnostic criteria. These can include subtle asymmetry in arm swing when walking, slight slowing of fine motor tasks, or a barely perceptible change in handwriting. Because each of these signs in isolation may have other explanations, clinicians consider their combination, progression over time, and accompaniment by non-motor features when assessing whether further neurological evaluation is warranted.
One of the central challenges in recognizing prodromal Parkinson's disease is that many of its early features overlap with common experiences of aging. Constipation, sleep disruption, occasional forgetfulness, and mild mood changes are all prevalent in older adults for reasons entirely unrelated to Parkinson's. Many prodromal symptoms, including hyposmia, possible RBD, depression, and anxiety, are detectable in a meaningful proportion of late middle-aged adults, most of whom will not go on to develop Parkinson's.
What distinguishes clinically significant early signals from incidental findings is typically their combination, their persistence without an alternative explanation, and their progression over time. While no single prodromal symptom confirms a diagnosis of Parkinson's disease, unexplained anosmia (loss of sense of smell) without an identifiable alternative cause may be associated with an elevated risk for eventual diagnosis, a risk that rises further when RBD or chronic constipation is also present. Clinicians generally do not interpret any one of these findings in isolation but rather assess them as part of a broader clinical picture that evolves across multiple visits and over time.
There is no consensus screening protocol for prodromal Parkinson's in the general population, and a formal diagnosis of Parkinson's disease still requires the presence of motor symptoms evaluated by a qualified clinician. However, specialists consistently advise that individuals who notice a persistent, unexplained loss of smell, chronic constipation without a clear cause, episodes of acting out dreams during sleep, or late-onset depression or anxiety should discuss these changes with a healthcare provider, particularly if multiple symptoms are present or if they seem to be progressing.
A neurologist or movement disorder specialist can evaluate these findings in a clinical context, consider alternative explanations, and determine whether monitoring or further assessment is appropriate. Early engagement with a clinician does not mean a diagnosis is imminent or inevitable, but it creates an informed framework for tracking changes over time and ensures that any progression is observed by someone with the clinical expertise to interpret it.
If you or someone you care about has questions about early symptoms of Parkinson's disease, environmental or occupational exposures that may be associated with Parkinson's, or how to find the right medical guidance, reliable information is a meaningful first step. Explore Injury Info for more educational resources.
Slow movement may be an early warning sign of Parkinson’s disease. Learn how bradykinesia develops and impacts mobility.
Learn how tremors differ from other movement symptoms in Parkinson’s disease and when to seek medical guidance.
Learn about the long-term financial impact of Parkinson’s disease, including medical costs, caregiving expenses, and links to paraquat exposure.
© 2026, Injury Info. All rights reserved.